» Articles » PMID: 38774507

Unraveling the Potential of Graphene Quantum Dots Against Infection

Abstract

Introduction: The emergence of drug-resistant strains has underscored the urgent need for novel therapeutic approaches. Carbon-based nanomaterials, such as graphene oxide (GO), have shown potential in anti-TB activities but suffer from significant toxicity issues.

Methods: This study explores the anti-TB potential of differently functionalized graphene quantum dots (GQDs) - non-functionalized, L-GQDs, aminated (NH-GQDs), and carboxylated (COOH-GQDs) - alone and in combination with standard TB drugs (isoniazid, amikacin, and linezolid). Their effects were assessed in both axenic cultures and infection models.

Results: GQDs alone did not demonstrate direct mycobactericidal effects nor trapping activity. However, the combination of NH-GQDs with amikacin significantly reduced CFUs in models. NH-GQDs and COOH-GQDs also enhanced the antimicrobial activity of amikacin in infected macrophages, although L-GQDs and COOH-GQDs alone showed no significant activity.

Discussion: The results suggest that specific types of GQDs, particularly NH-GQDs, can enhance the efficacy of existing anti-TB drugs. These nanoparticles might serve as effective adjuvants in anti-TB therapy by boosting drug performance and reducing bacterial counts in host cells, highlighting their potential as part of advanced drug delivery systems in tuberculosis treatment. Further investigations are needed to better understand their mechanisms and optimize their use in clinical settings.

Citing Articles

Exploration of the Graphene Quantum Dots-Blue Light Combination: A Promising Treatment against Bacterial Infection.

Rosato R, Santarelli G, Augello A, Perini G, De Spirito M, Sanguinetti M Int J Mol Sci. 2024; 25(15).

PMID: 39125603 PMC: 11312127. DOI: 10.3390/ijms25158033.

References
1.
Perini G, Palmieri V, Ciasca G, DAscenzo M, Gervasoni J, Primiano A . Graphene Quantum Dots' Surface Chemistry Modulates the Sensitivity of Glioblastoma Cells to Chemotherapeutics. Int J Mol Sci. 2020; 21(17). PMC: 7503375. DOI: 10.3390/ijms21176301. View

2.
De Maio F, Palmieri V, Salustri A, Perini G, Sanguinetti M, De Spirito M . Graphene oxide prevents mycobacteria entry into macrophages through extracellular entrapment. Nanoscale Adv. 2022; 1(4):1421-1431. PMC: 9419007. DOI: 10.1039/c8na00413g. View

3.
Ahmad F, Rani A, Alam A, Zarin S, Pandey S, Singh H . Macrophage: A Cell With Many Faces and Functions in Tuberculosis. Front Immunol. 2022; 13:747799. PMC: 9122124. DOI: 10.3389/fimmu.2022.747799. View

4.
Rey-Jurado E, Tudo G, Soy D, Gonzalez-Martin J . Activity and interactions of levofloxacin, linezolid, ethambutol and amikacin in three-drug combinations against Mycobacterium tuberculosis isolates in a human macrophage model. Int J Antimicrob Agents. 2013; 42(6):524-30. DOI: 10.1016/j.ijantimicag.2013.07.014. View

5.
Vilcheze C, Hartman T, Weinrick B, Jain P, Weisbrod T, Leung L . Enhanced respiration prevents drug tolerance and drug resistance in . Proc Natl Acad Sci U S A. 2017; 114(17):4495-4500. PMC: 5410800. DOI: 10.1073/pnas.1704376114. View